Author:
Shah Navnit,Sandhu Harpreet,Choi Duk Soon,Chokshi Hitesh,Iyer Raman,Malick A.Waseem
Reference26 articles.
1. Albano A, Phuapradit W, Sandhu H, Shah N (2002) Amorphous form of cell cycle inhibitor having improved solubility and bioavailability. U.S. Patent. 6,350,786
2. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O’Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA, Group B-S (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364(26):2507–2516
3. Chiou WL, Riegelman S (1970) Oral absorption of griseofulvin in dogs: increased absorption via solid dispersion in polyethylene glycol 6000. J Pharm Sci 59(7):937–942
4. Curatolo W, Nightingale J, Herbig S (2009) Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu. Pharm Res 26(6):1419–1431
5. De Yoreo JJ, Vekilov PG (2003) Principles of crystal nucleation and growth. Rev Mineral Geochem 54(1):57–93
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献